chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Itching injection site left arm after Bivalent booster; Spreading reaction injection site left arm after Bivalent booster; Red injection site left arm after Bivalent booster; This spontaneous case was reported by a patient and describes the occurrence of VACCINATION SITE PRURITUS (Itching injection site left arm after Bivalent booster), VACCINATION SITE REACTION (Spreading reaction injection site left arm after Bivalent booster) and VACCINATION SITE ERYTHEMA (Red injection site left arm after Bivalent booster) in a 74-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7148B) for COVID-19 vaccination.     Concurrent medical conditions included Blood cholesterol abnormal. Concomitant products included VITAMINS NOS for an unknown indication.    On 28-Sep-2022, the patient received fifth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 29-Sep-2022, the patient experienced VACCINATION SITE PRURITUS (Itching injection site left arm after Bivalent booster), VACCINATION SITE REACTION (Spreading reaction injection site left arm after Bivalent booster) and VACCINATION SITE ERYTHEMA (Red injection site left arm after Bivalent booster). At the time of the report, VACCINATION SITE PRURITUS (Itching injection site left arm after Bivalent booster), VACCINATION SITE REACTION (Spreading reaction injection site left arm after Bivalent booster) and VACCINATION SITE ERYTHEMA (Red injection site left arm after Bivalent booster) outcome was unknown.            Patient was taking Cholesterol Medication. It was reported that patient received 2 primary and 2 Monovalent Booster shots of Moderna COVID-19 vaccine. On 21-Jan-2021 (lot 029L20A) patient received the first dose of Moderna Vaccine. On 18-Feb-2021 (lot 013M20A) patient received the second dose of Moderna Vaccine. On 25-Oct-2021 (lot 039D21K) patient received the first booster dose of Moderna Vaccine. On 26-May-2022 (lot 038A22A) patient received the second booster dose of Moderna Vaccine. It was reported that 24 hrs after receiving the bivalent booster patient had injection site was red, itching, and spreading. No treatment information was provided.
PATIENT HAD GOTTEN THE SHINGLES VACCINE. NO REACTIONS THE FOLLOWING DAY WITH THE EXCEPTION OF SORENESS AT THE INJECTION SITE. 7 DAYS LATER, SHE HAD A BAD HEADACHE. ON THE 8TH DAY, SHE GOT A RASH AND HER DOCTOR CONFIRMED IT AS SHINGLES. I TOLD THE PATIENT THAT THIS IS NOT A LIVE ATTENUATED VACCINE AND SHOULD NOT GIVE HER THE SHINGLES, AND HER DOCTOR TOLD HER THE SAME THING. SUGGESTED THAT THIS IS MOST LIKELY A BAD COINCIDENCE. I AM REPORTING THIS AT THE PATIENTS REQUEST AND ALSO TO HAVE THIS ON RECORD IN  CASE THERE ARE SIMILAR REPORTING IN THE FUTURE.
It was a Tdap but I wasn't sure which one (there were multiple options to choose from). I broke out in a rash that worsened over the next 2 days. The rash was all over my upper arms (tricep/bicep area) and all over my thighs (front and back), hips and butt. It was swollen/inflammed and a bit itchy.
Around 5 min. after vaccination patient's arm was red and itching around 3in x 3in size.  Applied cold compress then ice pack.  Stayed in waiting room for 15 min. and then advised to give BENADRYL & TYLENOL and call Dr.  Mom phoned back 30 min later had given BENADRYL & ibuprofen.  Stated itching was getting better.
His fever started to go up, and he was very quiet. He was flushed and lethargic. On the second day of the fever, it spiked to 103.2, and I gave him a sponge bath with peppermint oil and gave him Tylenol and Ibuprofen, which started to bring it down. On the fourth day, the fever was in the low 101 range and broke the next day. I took him to the walk in clinic, and he was tested for COVID and strep throat. He went back to normal.
On day 7 , Swollen lymph node under left armpit, day 7, swelling and rash at injection site, day 7 tiredness,  headache on day 6 .
right arm site pain; Extreme nausea; Vomiting; Fatigue; Rash at injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (right arm site pain), NAUSEA (Extreme nausea), VOMITING (Vomiting), FATIGUE (Fatigue) and VACCINATION SITE RASH (Rash at injection site) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Multiple sclerosis.   On 06-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 04-Apr-2021, the patient experienced VACCINATION SITE PAIN (right arm site pain), NAUSEA (Extreme nausea), VOMITING (Vomiting), FATIGUE (Fatigue) and VACCINATION SITE RASH (Rash at injection site). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency and ARNICA MONTANA (ARNICA (PLANTA TOTA) "WELEDA") at an unspecified dose and frequency. At the time of the report, VACCINATION SITE PAIN (right arm site pain), NAUSEA (Extreme nausea), VOMITING (Vomiting), FATIGUE (Fatigue) and VACCINATION SITE RASH (Rash at injection site) outcome was unknown.            Patient could not keep anything such as water & could not keep pain killers down. She experienced fatigue & it carried over on the 2nd day and got worse on 3rd day and stated that nausea was discouraging. She stated that her rash was not intense but felt hurt afterwards.  Concomitant products were not provided.could not keep anything down   This case was linked to MOD-2021-067374 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 13-Jul-2021: Follow-up received on 13-JUL-2021 contains No new information.
61 y/o F, PMHx of metastatic invasive ductal carcinoma of right breast with right chest wall fungating wound, CHFpEF, hx of provoked PE, who presents from Applewood SAR after being febrile since 9/21/2021. Patient was recently hospitalized for right chest wall fungating wound and was discharged on mupirocin, sodium hypochlorite, and silver sulfadiazine. Patient had a Tmax of 102. 6 F. Patient had a CXR on 9.21 that showed RLL infiltrate a few days ago and was started on Levaquin po. Repeat CXR on 9/23 showed improvement in infiltrate. However, patient continued to be febrile and antibiotics were changed to IV Vancomycin and IV cefepime which the patient did not get at Applewood as she was unable to get an IV access. Patient was also noted to be hypotensive and tachycardic and was then sent to CSMC. Patient reports that since she has been at Applewood, she is doing okay. Does report a worsening dry cough and fatigue. Denies SOB, chest pain, abdominal pain, nausea, vomiting, dysuria, increased urinary frequency or urgency, or weakness. She has been fully vaccinated with Pfizer vaccines.
I have had two cases of severe itching and rash on my stomach, legs, and arms. The end of july for nearly 2 weeks I had the itchiness and I had to go to the doctor and be put on steroids to get it under control because everything else we tried was not working (allergy medicine, supplements). The second episode started 9/23/21 and is still occurring now. I am in contact with my doctor as it continues to worsen each day.
Pain at the injection site, headache, chills, fevers, body aches, diarrhea, extreme fatigue. Pain at the injection site was first. It became worse to the point that it hurt to move my arm too much the next night the second day my arm felt worse. Early morning on day two the fevers chills body aches and diarrhea started. By the end of day two exhaustion and headache. I had a doctor visit as I was only feeling worse. Today I still am having issues with the diarrhea, fever, chills, headache, exhaustion, and arm pain. The doctor told me to take Tylenol for the fevers, a compress for the arm pain , Imodium for the diarrhea, to keep hydrated and to rest. If I do not start feeling better  or I get worse, he told me to make another appointment.
This spontaneous report was received from a male patient of unknown age who was reporting on himself. Information regarding the patient's medical history, concurrent conditions or concomitant therapy was not provided. Approximately in 2006 (reported as "9 years ago"), the patient was vaccinated with ZOSTAVAX, subcutaneous injection (dose, lot number and expiration date were not provided). The patient reported that since an unknown date, since he was vaccinated, had been diagnosed with having a new case of shingles every year since the vaccination. Each time, he was treated in unspecified clinics with unspecified antiviral medications. At the time of this report, the outcome of shingles was unknown. Additional information is not expected as the reporter did not wish to be contacted.
Expired vaccine used; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) in a 66-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). On 05-Nov-2021, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant and treatment drugs were reported. The vaccine was stored in the freezer and one to two vials were taken out and placed in fridge each day  as needed.
Keloid formation devoloped at site of smallpox vaccination given on 17 Aug 2007.
Nausea; Lightheadedness; This spontaneous case was reported by a consumer and describes the occurrence of NAUSEA (Nausea) and DIZZINESS (Lightheadedness) in a 71-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 01320A and 006B21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.   On 17-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 21-Mar-2021, the patient experienced NAUSEA (Nausea) and DIZZINESS (Lightheadedness). At the time of the report, NAUSEA (Nausea) and DIZZINESS (Lightheadedness) outcome was unknown. Not Provided          No relevant concomitant medication was reported.  Treatment information was not provided.
Pt is 65 years old.  Technician entered fluzone HD but wrote "fluBlok HD" on the form.  The handheld device would not come up so the only double check was the QCPF.. It was folded in half lengthwise and only "flublok" was visible.   I did not do the subtraction but looked like she was near 65.  I told pt I was giving her flublok quad as I was administering it.  I told her it was for pts under 65 yo and she said "I am 65 years old".  We discussed the minimal difference in response that was likely with the lower dose at her current age.  Pt did not seem concerned when she left.
Within a few hours after the shot I started to have itching that progressed to hives all over body. (Hives persisted off and on for several weeks after). Later that night started feeling weak and confused/dizzy- severe headache. Generalized malaise for several days after but the itching and hives was by far the worst symptom.
2 month old female infant who developed leg swelling and erythema after receiving vaccinations today at PMD's office. After returning home, child developed fevers to 100.8 and right thigh received PCV-13 and developed erythema, swelling and tenderness from ankle to inguinal crease.  Left thigh received Pentacel and developed scattered petechiae, and purpura.
Pneumonia; Atrial fibrillation; This is a spontaneous report from a contactable consumer.  An 84-year-old patient of an unspecified gender received the 2nd dose of bnt162b2 (BNT162B2), intramuscular, administered in Arm on 26Jan2021 11:00 (Batch/Lot Number: FC3182) as DOSE 2, SINGLE for COVID-19 immunisation. Medical history included ongoing Crohn's disease, Parkinson's disease from 2021 and ongoing, ongoing diabetes mellitus. Concomitant medications included l-dopa (L-DOPA) taken for Parkinson's disease from 2021 and ongoing; metformin (METFORMIN) taken for diabetes mellitus from an unspecified start date and ongoing; furosemide (FUROSEMIDE) taken for an unspecified indication from an unspecified start date and ongoing; oxybutynin (OXYBUTYNIN) taken for an unspecified indication from an unspecified start date and ongoing; carbidopa, levodopa (RYTARY, strength 48.75/195) taken for an unspecified indication from an unspecified start date and ongoing; vedolizumab (ENTYVIO) taken for Crohn's disease from an unspecified start date and ongoing. Previously the patient received the 1st dose of bnt162b2 (BNT162B2, Manufacturer Pfizer-BioNTech) (Batch/Lot number: EL3246) on 05Jan2021 at 84 years for COVID-19 immunisation. The patient experienced pneumonia (caused hospitalization, medically significant) on 20Jul2021 with outcome of recovering, atrial fibrillation (caused hospitalization, medically significant) on 20Jul2021 with outcome of recovering. The events required emergency room visit. The patient was hospitalized for 4 days. Therapeutic measures were taken as a result of the events.  The lot number for bnt162b2 was not provided and will be requested during follow-up.
Client stated on 11/5/08 - that the next day after the immunizations-she traveled with friends and suddenly could not breath. She was treated at hospital. States was given epinephrine and fluids and placed on prednisone. Dr. told her it not a vaccine reaction.
severe case of the chills. had to sleep wearing additional 2 swearshirts and 1 pair of winter sweatpants over my pajamas
PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE ACUTE DVT OF LEFT LEG, UNSPECIFIED VEIN
I started getting really itchy on the tops of my feet. Once I started itching it, these bumps started appearing. I started getting itchy on the top of my right hand and top of the wrist. And a little on the forearm. Also, at the back of the forearm/end of forearm. Those were the main areas where I got bumps and itchiness. So, I went to the urgent care, and they weren't completely sure what it was. They said it was probably a rash. He said it looked like bed bug bites, but thought it was probably a rash. So, I was given hydrocortisone cream and I was also given permethrin cream. I was given medication that I only took 5 of prednisone tablets. After a few days, the bumps started subsiding and right now, there's still scars from the bumps. You can see dark spots where the bumps used to be, but the bumps are gone now. It's not itchy anymore. The bumps were also on my legs, I think about the knee. In between the knee and calf. It was mostly on the tops of my feet and on the top of my right hand and forearm. I didn't use most of the mediation, I did use the permethrin cream for the one night I was supposed to, and the hydrocortisone cream a few times. 2-3 times. I probably only took like 2 of the prednisone tablets. The bumps mostly seem to subside without use of the medication. Just over time, a couple days. We never figured out why or how I got the rash. I noted that I didn't eat anything that could really trigger this, so we were unsure of how this happened.
Pt developed a rash, body aches and fever & fatigue 17 days after varicella vaccine administration. Rash was < 50 pox - but pt felt "very sick" symptoms last for 5 days. Patient was given varicella one day postpartum prior to hospital discharge. Because she developed rash - her 3 week old baby received varicella gamma globulin as a precautionary measure.
COVID 19; COVID 19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 70-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 05Oct2021 as dose 3 (booster), single (Batch/Lot number: unknown), in left arm and on 29Apr2022 as dose 4 (booster), single (Batch/Lot number: unknown), in left arm for COVID-19 immunization; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for COVID-19 immunization. The patient's relevant medical history included: "high blood pressure under control with medication" (unspecified if ongoing), notes: high blood pressure under control with, medication. There were no concomitant medications. Past drug history included: Aspirin, reaction(s): "known allergies aspirin", notes: known allergies aspirin. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "recovering" and all described as "COVID 19". The patient underwent the following laboratory tests and procedures: COVID-19 test: Positive. Therapeutic measures were taken as a result of drug ineffective, covid-19.  Additional information: The patient did not received other medication in 2 weeks.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Bumps at injection; Injection site warm; Injection site redness; Injection site itch; Sore/arm was painful/tender to touch/skin near the injection site feels rough; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE URTICARIA (Bumps at injection), VACCINATION SITE WARMTH (Injection site warm), VACCINATION SITE ERYTHEMA (Injection site redness), VACCINATION SITE PRURITUS (Injection site itch) and VACCINATION SITE PAIN (Sore/arm was painful/tender to touch/skin near the injection site feels rough) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 07-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Jan-2021, the patient experienced VACCINATION SITE URTICARIA (Bumps at injection), VACCINATION SITE WARMTH (Injection site warm), VACCINATION SITE ERYTHEMA (Injection site redness), VACCINATION SITE PRURITUS (Injection site itch) and VACCINATION SITE PAIN (Sore/arm was painful/tender to touch/skin near the injection site feels rough). At the time of the report, VACCINATION SITE URTICARIA (Bumps at injection) had resolved and VACCINATION SITE WARMTH (Injection site warm), VACCINATION SITE ERYTHEMA (Injection site redness), VACCINATION SITE PRURITUS (Injection site itch) and VACCINATION SITE PAIN (Sore/arm was painful/tender to touch/skin near the injection site feels rough) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant product use was reported  No treatment details were provided.
Pt recvd 3rd dose of vax 4DEC91 & on 6DEC91 devel chest/throat tightness, wheezing & erythematous rash; transferred to hosp & was observed for 2 nocs under care of MD;
After getting the Covid-19 vaccine about a week later my psoriasis became worse covering more of my body. The patches were bigger and more irritated. I was prescribed Clobetasol 0.05mg. The medication did not work. I am going back to the doctor tomorrow.
Ct. was to receive a TB skin test on 8/16/04 instead Ct. received Adult Td ID in left forearm. Ct. seen by PA-C at school based health center.
Initial report received from a consumer on 18 November 2014. A 46-year-old male patient had received a dose of TD VACCINE (batch number, route of administration, dose and dose in series was not reported) and TB SKIN TEST (batch number, route of administration, site of administration, dose and dose in series was not reported) on 17 November 2014. Illness at time of vaccination was none as per reporter and patient had no known allergies and pre-existing physician diagnosed allergies birth defects, medical condition and concomitant medications was not reported. On 17 November 2014, same day after vaccination, the patient experienced headache and nausea. On 18 November 2014 the patient experienced head pain, "explosive diarrhea" and weakness of legs that "can barely walk". Laboratory investigations and corrective treatment was not reported. At the time of this report the patient was not recovered from the event. Documents held by sender: none.
sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Jan-2021, the patient experienced PAIN IN EXTREMITY (sore arm). At the time of the report, PAIN IN EXTREMITY (sore arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication details were not reported by the reporter. Treatment medication details was not reported by the reporter.
After receiving the vaccine, the next day I became very dizzy, vertigo like dizziness but no nausea or headache.
Side effects after receiving the second dose; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Side effects after receiving the second dose) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Feb-2021, the patient experienced VACCINATION COMPLICATION (Side effects after receiving the second dose). At the time of the report, VACCINATION COMPLICATION (Side effects after receiving the second dose) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication details were not reported by the reporter. Treatment details was not reported by the reporter.
Abdominal pain, cough, wheezing, hives treated with epinephrine, diphenhydramine, albuterol.
On the day of the administration of the 1st dose of Shingrix, adverse events were reported as feeling like "hit by fright train", extremely exhausted at night, joint hurts, and extreme body aches. The next day of the administration, the symptoms got better
I seem to have an ongoing case of tendonitis in my right arm ever since I got the vaccine.  It doesn't hurt all the time, but when (for example) I pull out the pitcher of water out of the fridge or grab the bag of cereal out of the pantry, I experience mild pain in my right deltoid, and I don't have as much strength or stability as I used to have.
patient developed diffuse red itchy rash on chest, back, arms. benadryl and hydrocortisone cream were not effective. She went to Emergency room and was given a 5 day tx of prednisone 40mg daily by mouth for 5 days
On 3/14/01, used a 1" needle. On 3/15/01, had shooting pain down left arm when she raised it. Also has pain when she rotates arm. No redness or swelling. Applying cold compresses bid. I 600mg.
ROTATEQ given & patient vomited for weeks & some initial vomiting was tinged with blood & ran fever.